ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 291

$745K Total Retail Price of All Prescriptions

Rank: 63 out of 291

407 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in West Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 475 422 124 1 4
PRAVASTATIN SODIUM 409 373 111 2 16
AMLODIPINE BESYLATE 347 334 87 3 7
LEVOTHYROXINE SODIUM 318 258 64 4 2
LISINOPRIL 312 287 87 5 3
METOPROLOL TARTRATE 293 272 62 6 10
METOPROLOL SUCCINATE 275 249 65 7 13
FUROSEMIDE 258 231 60 8 6
HYDROCODONE-ACETAMINOPHEN 254 202 52 S3 9 1
WARFARIN SODIUM 233 205 37 10 15
ATORVASTATIN CALCIUM 200 165 53 11 8
CLONAZEPAM 188 149 36 B 12 37
METFORMIN HCL ER 173 128 51 13 81
TRAMADOL HCL 173 158 53 13 24
SERTRALINE HCL 163 135 37 15 26
GLIMEPIRIDE 161 142 39 16 31
POTASSIUM CHLORIDE 151 146* 23 17 17
ATENOLOL 144 139* 33 18 19
HYDROCHLOROTHIAZIDE 138 138 39 19 18
CLOPIDOGREL 131 126* 26 20 11
LOSARTAN POTASSIUM 125 120* 36 21 21
GABAPENTIN 117 112* 31 22 12
PAROXETINE HCL 111 88 28 23 65
PANTOPRAZOLE SODIUM 101 82 28 24 28
PROAIR HFA 99 88 50 25 36
KLOR-CON M20 99 87 24 25 45
CLONIDINE HCL 98 93* 26 27 53
RANITIDINE HCL 95 82 29 28 33
ACETAMINOPHEN-CODEINE 95 79 27 S3 28 172
CEPHALEXIN 91 86* 40 30 97
CARVEDILOL 84 79* 23 31 25
FLUTICASONE PROPIONATE 82 64 38 32 50
SIMVASTATIN 80 75* 20 33 5
ADVAIR DISKUS 80 69 31 33 51
NYSTATIN 78 73* 24 35 162
ALLOPURINOL 77 72* 22 36 41
CRESTOR 77 72* 18 36 23
NEXIUM 76 <11 <11 38 20
NAMENDA 75 <11 <11 39 43
METHYLPREDNISOLONE 72 67* 51 40 107
ENALAPRIL MALEATE 72 67* 18 40 80
ALPRAZOLAM 72 67* 21 B 40 14
DONEPEZIL HCL 71 71 11 43 34
DIGOX 69 64* 18 44 77
LEVOFLOXACIN 68 63* 53 45 71
DIOVAN 68 53 12 45 47
POLYETHYLENE GLYCOL 3350 66 46 30 47 82
AGGRENOX 64 64 12 48 328
LORAZEPAM 63 58* 16 B 49 22
ISOSORBIDE MONONITRATE ER 62 49 17 50 39
FENOFIBRATE* 62 62 18 50 60
HUMALOG 59 <11 <11 52 159
LANTUS SOLOSTAR 58 53* 21 53 83
CIPROFLOXACIN HCL 58 53* 36 53 73
METFORMIN HCL 57 52* 13 55 9
ALENDRONATE SODIUM 53 48* 17 56 69
ROPINIROLE HCL 53 <11 <11 56 62
SPIRIVA 52 47* 19 58 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 47* 40 58 104
CYMBALTA 50 <11 <11 60 40
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.